However, consistent with our previous findings in naïve mice [16], inclusion of Tween-40 in TA-CIN/GPI-0100 formulation did not significantly impact the anti-tumor effect or E6/E7-specific CD8+ T cell responses (Fig. 1D and S2B Fig.). Here, CD8A is linked to neoplasm.